310 related articles for article (PubMed ID: 28838357)
21. Ayurgenomics for stratified medicine: TRISUTRA consortium initiative across ethnically and geographically diverse Indian populations.
Prasher B; Varma B; Kumar A; Khuntia BK; Pandey R; Narang A; Tiwari P; Kutum R; Guin D; Kukreti R; Dash D; ; Mukerji M
J Ethnopharmacol; 2017 Feb; 197():274-293. PubMed ID: 27457695
[TBL] [Abstract][Full Text] [Related]
22. The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
Titeux M; Izmiryan A; Hovnanian A
J Invest Dermatol; 2017 May; 137(5):e123-e129. PubMed ID: 28411843
[TBL] [Abstract][Full Text] [Related]
23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
24. What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation.
Tabor HK; Goldenberg A
AMA J Ethics; 2018 Sep; 20(9):E834-840. PubMed ID: 30242814
[TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing applied to rare diseases genomics.
Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
[TBL] [Abstract][Full Text] [Related]
26. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
[TBL] [Abstract][Full Text] [Related]
27. Exploring human biology with N-of-1 clinical trials.
Schork NJ; Beaulieu-Jones B; Liang WS; Smalley S; Goetz LH
Camb Prism Precis Med; 2023; 1():. PubMed ID: 37255593
[TBL] [Abstract][Full Text] [Related]
28. Advancing clinical cohort selection with genomics analysis on a distributed platform.
Smith JM; Lathara M; Wright H; Hill B; Ganapati N; Srinivasa G; Denny CT
PLoS One; 2020; 15(4):e0231826. PubMed ID: 32324802
[TBL] [Abstract][Full Text] [Related]
29. TBI Rehabilomics Research: an Exemplar of a Biomarker-Based Approach to Precision Care for Populations with Disability.
Wagner AK
Curr Neurol Neurosci Rep; 2017 Sep; 17(11):84. PubMed ID: 28929311
[TBL] [Abstract][Full Text] [Related]
30. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
31. USE OF GENOME DATA IN NEWBORNS AS A STARTING POINT FOR LIFE-LONG PRECISION MEDICINE.
Brenner SE; Kingsmore S; Mooney SD; Nussbaum R; Puck J
Pac Symp Biocomput; 2016; 21():568-75. PubMed ID: 26776219
[TBL] [Abstract][Full Text] [Related]
32. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
33. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
34. PhenoDis: a comprehensive database for phenotypic characterization of rare cardiac diseases.
Adler A; Kirchmeier P; Reinhard J; Brauner B; Dunger I; Fobo G; Frishman G; Montrone C; Mewes HW; Arnold M; Ruepp A
Orphanet J Rare Dis; 2018 Jan; 13(1):22. PubMed ID: 29370821
[TBL] [Abstract][Full Text] [Related]
35. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
[TBL] [Abstract][Full Text] [Related]
36. Public health and precision medicine share a goal.
Vaithinathan AG; Asokan V
J Evid Based Med; 2017 May; 10(2):76-80. PubMed ID: 28276633
[TBL] [Abstract][Full Text] [Related]
37. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract][Full Text] [Related]
38. Rare diseases: Genomics, plain and simple.
Gura T
Nature; 2012 Feb; 483(7387):20-2. PubMed ID: 22382959
[No Abstract] [Full Text] [Related]
39. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
Maggi E; Montagna C
Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
